京東(09618.HK):會結合ChatGPT方法和技術融入「言犀」等服務系統中
對於近期大熱的聊天機械人ChatGPT,據《澎湃新聞》引述京東集團(09618.HK)(JD.US)副總裁何曉冬告表示,京東在ChatGPT領域擁有豐富的場景和高質量的數據,如京東雲「言犀」每天和用戶進行1,000萬次的交互,認為ChatGPT是令人興奮的前沿探索,「言犀」則是大規模商用的客戶服務系統,未來京東會不斷結合ChatGPT的方法和技術點,融入到產品服務中來,推動人工智能(AI)的產業落地。
他認為,相較於傳統聊天機械人,京東場景更加垂直,更加聚焦於任務型多輪對話,考量是對話的精準度、客戶的滿意度,滿足成本、體驗、價格、產品及服務等要素的要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.